3.80Open10.75Pre Close6 Volume1 Open Interest83.00Strike Price2.40KTurnover49.46%IV0.16%PremiumDec 13, 2024Expiry Date4.07Intrinsic Value100Multiplier1DDays to Expiry0.13Extrinsic Value100Contract SizeAmericanOptions Type-0.9866Delta0.0231Gamma19.37Leverage Ratio-0.0294Theta-0.0009Rho-19.11Eff Leverage0.0013Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet